£113.76

Springer Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance: From Basic to Clinical Research

Price data checked 1 day ago

View at Amazon

Price History & Forecast

Last 90 days • 90 data points

Historical
Generating forecast...
£113.76 £113.05 £113.20 £113.36 £113.51 £113.67 £113.83 11 February 2026 05 March 2026 27 March 2026 18 April 2026 11 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
85 days 5 days · current 0 21 43 64 85 £113 £114 Days at Price

Price Analysis

Most common price: £113 (85 days, 94.4%)

Price range: £113 - £114

Price levels: 2 different prices over 90 days

Description

Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
08 October 2012
Listed Since
06 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Sex-steroid Interactions with Growth Hormone (Serono Symposia)
80% match

Sex-steroid Interactions with Growth Hormone (Serono Symposia)

Springer

£111.50 04 May 2026
Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function
80% match

Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function

Springer

£65.57 11 May 2026
Bioactive Essential Oils and Cancer
80% match

Bioactive Essential Oils and Cancer

Springer

£107.98 11 May 2026
Retinoids in Oncology (ESO Monographs)
80% match

Retinoids in Oncology (ESO Monographs)

Springer

£113.93 04 May 2026
Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients
79% match

Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients

Springer

£73.10 04 May 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
79% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£83.97 11 May 2026
Cell Signaling & Molecular Targets in Cancer
79% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Dipeptidyl Aminopeptidases: Basic Science and Clinical Applications: 575 (Advances in Experimental Medicine and Biology, 575)
79% match

Dipeptidyl Aminopeptidases: Basic Science and Clinical Applications: 575 (Advances in Experimental Medicine and Biology, 575)

Springer

£118.13 04 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
79% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 11 May 2026
Proteases and Their Inhibitors in Cancer Metastasis: 4 (Cancer Metastasis - Biology and Treatment, 4)
78% match

Proteases and Their Inhibitors in Cancer Metastasis: 4 (Cancer Metastasis - Biology and Treatment, 4)

Springer

£108.95 11 May 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
78% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 11 May 2026
GHRH, GH, and IGF-I: Basic and Clinical Advances (Serono Symposia USA)
78% match

GHRH, GH, and IGF-I: Basic and Clinical Advances (Serono Symposia USA)

Springer

£146.00 04 May 2026
Glycosignals in Cancer: Mechanisms of Malignant Phenotypes
78% match

Glycosignals in Cancer: Mechanisms of Malignant Phenotypes

Springer

£75.48 11 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
78% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
78% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£147.83 11 May 2026
Neuroendocrine and Oral Cancers: An Interdisciplinary Approach (Interdisciplinary Cancer Research, 14)
78% match

Neuroendocrine and Oral Cancers: An Interdisciplinary Approach (Interdisciplinary Cancer Research, 14)

Springer

£174.99 11 May 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
78% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£123.38 11 May 2026
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
78% match

Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects

Springer

£147.11 04 May 2026
Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)
78% match

Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)

Springer

£141.08 04 May 2026
Hormone Therapy and Castration Resistance of Prostate Cancer
78% match

Hormone Therapy and Castration Resistance of Prostate Cancer

Springer

£109.24 04 May 2026
Cell Signaling & Molecular Targets in Cancer
78% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Neuroendocrine Tumors in Real Life: From Practice to Knowledge
78% match

Neuroendocrine Tumors in Real Life: From Practice to Knowledge

Springer

£108.56 11 May 2026
Tips and Tricks in Endocrine Surgery
78% match

Tips and Tricks in Endocrine Surgery

Springer

£65.57 11 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
77% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026